Controlled release osmotic infusion system

• US 5,257,987 A
• Filed: 05/21/1990
• Issued: 11/02/1993
• Est. Priority Date: 05/21/1990
• Status: Expired due to Fees

• Current Assignee: Pharmetrix Corporation
• Original Assignee: Pharmetrix Corporation
• Inventors: Faste, Rolf A., Athayde, Amulya L.
• Primary Examiner(s): NOT, DEFINED
• Assistant Examiner(s): Polutta, Mark O.
• Application Number:
  US07/526,120
• Time in Patent Office: 1,261 Days
• Field of Search: 604/892.1, 604/131, 604/141, 604/148, 604/151, 604/86, 604/87, 128/DIG. 12
• US Class Current: 604/892.1
• CPC Class Codes: A61M 2005/14513 with secondary fluid driving or regulating the infusion
• CPC Class Codes: A61M 5/14248 of the skin patch type
• CPC Class Codes: A61M 5/145 using pressurised reservoirs, e.g. pressurised by means of pistons
• CPC Class Codes: Y10S 128/12 Pressure infusion
• CPC Class Codes: Y10S 977/956 Of mechanical property

Abstract

A portable osmotic infusion device assembly, having two pouches in pressure transmitting relationship, the first containing infusate and the second, a driving fluid. The driving fluid is created and pressurized by activation of an osmotic pump, and the rate of infusion is controlled by a rate-controlling means. The infusate pouch is manufactured separately and can be stored apart from the rest of the system.

Claims

1. A portable infusion device assembly comprising:

a. a first pouch containing infusate and fitted with a dispensing nozzle;

b. a second pouch in pressure-transmitting relationship to the aforesaid first pouch;

c. an integral power source comprising;

a pressure-generating means for generating pressure in aforesaid second pouch, comprised of an osmagent and a liquid permeant, wherein a driving fluid is produced when permeant contacts osmagent;

an activating means for initiating the action of the aforesaid power generating means;

a rate-controlling means for regulating the volume change of the aforesaid first pouch, comprising a semipermeable membrane;

d. a fluid-transport means in liquid transmitting relationship between the aforesaid power chamber and the aforesaid delivery chamber, and,

e. a connecting means for attaching the aforesaid dispensing nozzle to the object of treatment; and

,

f. a housing containing the aforesaid first and second pouches and in restraining relationship to the aforesaid first and second pouch.

3. The device according to claim 1 where the inner space of the first infusate pouch is comprised of:

a. drug in dry form;

b. pharmaceutically acceptable solvent for said drug; and

,

c. a breakable seal in separating relationship to said drug and solvent.

7. The device of claim 1, where said pouch for containment of the infusate is loaded with infusate separately from the rest of the device assembly, and can then be inserted into said assembly.

9. The device of claim 1, where said activation means is comprised of a means of breaking a barrier separating the permeant from contact with the semipermeable membrane that is the rate-controlling means.

11. The device of claim 9, where:

a. said activation means is a plunger or other means of breaking said barrier; and

,

b. said barrier is a seal separating the permeant from contact with the semipermeable membrane.

13. The device according to claim 1 where the drug contained in the infusate pouch is heparin.

14. The device according to claim 1 where the drug contained in the infusate pouch is insulin.

17. The device according to claim 1 where the drug contained in the infusate pouch is fluorouracil.

19. The device according to claim 1 where the drug contained in the infusate pouch is cisplatin.

21. The device according to claim 1 where the drug contained in the infusate pouch is gancyclovir.

23. The device according to claim 1 where the drug contained in the infusate pouch is adriamycin.

2. A portable infusion device assembly comprising:

a. a first pouch containing infusate and fitted with a dispensing nozzle;

b. a second pouch in pressure-transmitting relationship to the aforesaid first pouch;

c. an integral power source comprising;

a pressure-generating means for generating pressure in aforesaid second pouch, comprised of an osmagent and a liquid permeant, wherein a driving fluid is produced when permeant contacts osmagent;

an activating means for initiating the action of the aforesaid power generating means;

a rate controlling means for regulating the volume change of the aforesaid first pouch, comprising a semipermeable membrane;

d. a fluid-transport means in liquid transmitting relationship between the aforesaid power chamber and the aforesaid delivery chamber, and,

e. a connecting means for attaching the aforesaid dispensing nozzle to the object of treatment; and

,

f. a housing containing the aforesaid first pouch, second pouch, and power source, and in restraining relationship with the aforesaid first and second pouches.

4. The device according to claim 2 where the inner space of the first infusate pouch is comprised of:

a. drug in dry form;

b. pharmaceutically acceptable solvent for said drug; and

,

c. a breakable seal in separating relationship to said drug and solvent.

8. The device of claim 2, where said pouch for containment of the infusate can be loaded with infusate separately from the rest of the device assembly, and is then be inserted into said assembly.

10. The device of claim 2, where said activation means is comprised of a means of breaking a barrier separating the permeant from contact with the semipermeable membrane that is the rate-controlling means.

12. The device of claim 10, where:

a. said activation means is a plunger or other means of breaking said barrier; and

,

b. said barrier is a seal separating the permeant from contact with the semipermeable membrane.

15. The device according to claim 2 where the drug contained in the infusate pouch is heparin.

16. The device according to claim 2 where the drug contained in the infusate pouch is insulin.

18. The device according to claim 2 where the drug contained in the infusate pouch is fluorouracil.

20. The device according to claim 2 where the drug contained in the infusate pouch is cisplatin.

22. The device according to claim 2 where the drug contained in the infusate pouch is gancyclovir.

24. The device according to claim 2 where the drug contained in the infusate pouch is adriamycin.

5. A method for infusing a patient, comprising connection of said patient to a portable infusion device, said device comprising:

a. a first pouch containing infusate and a dispensing nozzle;

b. a second pouch in pressure-transmitting relationship to the aforesaid first pouch;

c. an integral power source comprising;

a pressure-generating means for generating pressure in aforesaid second pouch, comprised of an osmagent and a liquid permeant, wherein a driving fluid is produced when permeant contacts osmagent;

an activating means for initiating the action of the aforesaid power generating means;

a rate-controlling means for regulating the volume change of the aforesaid first pouch, comprising a semipermeable membrane;

d. a connecting means for attaching the aforesaid dispensing nozzle to the object of treatment;

e. a housing containing the aforesaid first and second pouches and in restraining relationship to the aforesaid first and second pouches; and

,

f. activating said device.

6. A method for infusing a patient, comprising connection of said patient to a portable infusion device, said device comprising:

a. a first pouch containing infusate and a dispensing nozzle;

b. a second pouch in pressure-transmitting relationship to the aforesaid first pouch;

c. an integral power source comprising;

a pressure-generating means for generating pressure in aforesaid second pouch, comprised of an osmagent and a liquid permeant;

wherein a driving fluid is produced when permeant contacts osmagent;

an activating means for initiating the action of the aforesaid power generating means;

a rate controlling means for regulating the volume change of the aforesaid first pouch, comprising a semipermeable membrane;

d. a connecting means for attaching the aforesaid dispensing nozzle to the object of treatment;

e. a housing containing the aforesaid first pouch, second pouch, and power source, and in restraining relationship with the aforesaid first and second pouches; and

,

f. activating said device.